Article

Validation of the NovaSeq6000 Platform and automated library preparation for CE-IVD equivalence

2025-08-23

Abstract excerpt

The implementation of next-generation sequencing (NGS) technologies in clinical diagnostics requires rigorous validation of sequencing platforms and analytical workflows. In this study, we validated the performance of the Illumina NovaSeq6000 Research Use Only (RUO) platform, combined with automated library preparation using the Hamilton Microlab STAR system, by comparison to the CE-IVD certified NovaSeq6000Dx pla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 216f8749-049d-5687-8166-b05e2c370d12
DOI: 10.1101/2025.08.19.671033

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validation of the NovaSeq6000 Platform and automated library preparation for CE-IVD equivalenceDOI 10.1101/2025.08.19.671033Read

Analytical Validation of Short-Read Genome Sequencing for Diagnostic Panel and Exome Testing.Semantic proximity Read

Analytical and clinical validation of a genome sequencing-based comprehensive rare disease genomic profiling testSemantic proximity Read

Multi-modal benchmarking of the Ultima UG100 and Illumina NovaSeq sequencing platforms using clinically relevant FFPE tissuesSemantic proximity Read

Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applicationsSemantic proximity Read

Performance characterization of PCR-free whole genome sequencing for clinical diagnosisSemantic proximity Read

One in seven pathogenic variants can be challenging to detect by NGS: An analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementationSemantic proximity Read

Accurate somatic variant calling performance using Avidity Sequencing with Burning Rock’s OncoScreen <sup>TM</sup> Plus panelSemantic proximity Read

Benchmarking Q40 sequencing for sensitive and efficient detection of rare genomic variants.Semantic proximity Read

Q40 sequencing reduces costs and enhances detection of low- frequency somatic variantsSemantic proximity Read

Analytical validation of whole exome and whole genome sequencing for clinical applications.Semantic proximity Read

Quality assurance for next-generation sequencing diagnostics of rare neurological diseases in the European Reference NetworkSemantic proximity Read

Performance Evaluation of Whole-Genome Amplification Platforms for Clinical Next-Generation Sequencing with Minimal Nucleic Acid Input.Semantic proximity Read